YJR141W refers to a specific gene/protein in Saccharomyces cerevisiae (baker's yeast), identified by its systematic name in the Saccharomyces Genome Database. This protein (UniProt No. P47172) serves as an important research target for understanding fundamental cellular processes in yeast. While the search results don't specify the exact function of YJR141W, studying this protein contributes to our understanding of yeast biology, which serves as a model organism for eukaryotic cellular processes. Research involving YJR141W antibodies enables visualization and quantification of this protein in various experimental contexts, facilitating investigations into protein expression, localization, and interactions .
The YJR141W Antibody is characterized by several important specifications that determine its research applications:
| Specification | Details |
|---|---|
| Product Code | CSB-PA342466XA01SVG |
| Type | Polyclonal Antibody |
| Host | Rabbit |
| Immunogen | Recombinant S. cerevisiae (strain ATCC 204508/S288c) YJR141W protein |
| Species Reactivity | Saccharomyces cerevisiae (strain ATCC 204508/S288c) |
| Validated Applications | ELISA, Western Blot (WB) |
| Form | Liquid |
| Conjugate | Non-conjugated |
| Isotype | IgG |
| Purification Method | Antigen Affinity Purified |
These specifications inform researchers about the antibody's origin, specificity, and validated applications, which are essential considerations when planning experiments .
Proper storage of the YJR141W Antibody is critical for maintaining its activity and specificity. The antibody should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be avoided as they can degrade antibody quality and reduce binding efficiency. The antibody is supplied in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative, which helps maintain stability during storage .
For long-term experiments, it is advisable to aliquot the antibody into smaller volumes before freezing to minimize freeze-thaw cycles. When removing the antibody from storage, thaw it on ice and centrifuge briefly before opening to collect any solution that might have accumulated in the cap. Return unused portions to -20°C or -80°C promptly after use to preserve antibody integrity.
When optimizing Western Blotting with YJR141W Antibody, consider the following methodological approach:
Sample Preparation: Lyse yeast cells using appropriate buffers containing protease inhibitors to prevent protein degradation. Mechanical disruption (glass beads) is often necessary for efficient yeast cell lysis.
Protein Loading: Load 20-50 μg of total protein per lane, depending on the abundance of YJR141W in your samples.
Gel Electrophoresis: Use an appropriate percentage SDS-PAGE gel based on the molecular weight of YJR141W.
Transfer Conditions: Transfer proteins to a PVDF or nitrocellulose membrane using standard transfer conditions (e.g., 100V for 1 hour or 30V overnight).
Blocking: Block the membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
Primary Antibody Incubation: Dilute YJR141W Antibody (starting dilution 1:1000, then optimize) in blocking buffer and incubate overnight at 4°C.
Washing: Wash the membrane with TBST (3-5 times, 5 minutes each).
Secondary Antibody: Incubate with an appropriate HRP-conjugated anti-rabbit secondary antibody.
Detection: Develop using chemiluminescence and image using an appropriate detection system .
Each step may require optimization based on your specific experimental conditions and the expression level of YJR141W in your samples.
Incorporating appropriate controls is essential for interpreting results obtained with YJR141W Antibody:
Positive Control: Include a sample known to express YJR141W, such as the wild-type S. cerevisiae strain ATCC 204508/S288c.
Negative Control: Use a sample where YJR141W is absent or downregulated, such as a YJR141W knockout strain if available.
Loading Control: Probe for a constitutively expressed yeast protein (e.g., actin or GAPDH) to ensure equal protein loading across samples.
Antibody Controls:
Primary antibody omission control to assess non-specific binding of the secondary antibody
Isotype control (non-specific rabbit IgG) to evaluate background binding
Peptide Competition/Blocking: Pre-incubate the antibody with excess immunizing peptide to confirm signal specificity.
These controls help distinguish specific from non-specific signals and validate experimental findings when using YJR141W Antibody .
High background is a common challenge when working with antibodies. To mitigate this issue with YJR141W Antibody:
Optimize Blocking: Increase blocking time or try alternative blocking agents (BSA, casein, or commercial blocking buffers).
Adjust Antibody Concentration: Titrate the antibody to determine the optimal dilution that provides specific signal with minimal background.
Increase Washing Stringency: Extend washing times or add more washing steps using TBST with higher detergent concentration (up to 0.1% Tween-20).
Reduce Secondary Antibody Concentration: Lower the concentration of secondary antibody if background persists.
Filter Primary Antibody: Centrifuge the diluted antibody solution at high speed or pass through a 0.22μm filter to remove any aggregates that could cause non-specific binding.
Optimize Incubation Conditions: Try shorter incubation times at room temperature instead of overnight at 4°C, which might reduce non-specific binding.
Use Highly Purified BSA: Some BSA preparations can contain contaminants; using higher purity BSA may reduce background .
Systematic testing of these parameters can help identify the optimal conditions for reducing background while maintaining specific signal.
If you encounter weak or no signal when using YJR141W Antibody, consider these methodological solutions:
Increase Protein Concentration: Load more total protein to enhance detection if YJR141W is expressed at low levels.
Optimize Antibody Concentration: Try higher concentrations of primary antibody (1:500 or 1:250).
Extend Incubation Times: Increase primary antibody incubation to 48 hours at 4°C for low-abundance proteins.
Enhance Detection Method: Use more sensitive detection systems like enhanced chemiluminescence (ECL) or fluorescent secondary antibodies.
Improve Protein Extraction: For yeast samples, ensure complete cell lysis using optimized mechanical disruption methods in combination with chemical lysis buffers.
Reduce Transfer Time/Voltage: Lower voltage or shorter transfer times can prevent small proteins from passing through the membrane.
Verify Protein Expression: Confirm YJR141W expression in your samples through RT-PCR or other methods before antibody detection.
Check Antibody Viability: The antibody's made-to-order nature (14-16 weeks lead time) suggests potential batch variability; ensure proper storage and handling to maintain functionality .
Validating antibody specificity is crucial for reliable research outcomes. For YJR141W Antibody, consider these validation approaches:
Genetic Validation:
Compare signal between wild-type and YJR141W knockout strains
Use strains with tagged YJR141W (e.g., GFP-tagged) to confirm colocalization of signals
Biochemical Validation:
Perform peptide competition assays by pre-incubating the antibody with excess immunizing peptide
Demonstrate signal reduction/elimination in samples where YJR141W expression is suppressed
Molecular Weight Verification:
Confirm that the detected band appears at the expected molecular weight for YJR141W
Use mass spectrometry to verify the identity of the detected band
Multiple Detection Methods:
Compare results from different applications (ELISA vs. Western blot)
Use alternative antibodies targeting different epitopes of YJR141W, if available
Assay-Specific Controls:
For ELISA: Include gradient dilutions to demonstrate dose-dependent signal
For Western blot: Include molecular weight markers and demonstrate signal specificity through titration
These validation strategies collectively strengthen confidence in results obtained with the YJR141W Antibody .
YJR141W Antibody can be employed in various protein-protein interaction studies using these methodological approaches:
Co-Immunoprecipitation (Co-IP): Use YJR141W Antibody to pull down YJR141W protein complexes from yeast lysates. After immunoprecipitation, analyze the co-precipitated proteins by mass spectrometry or Western blotting with antibodies against suspected interaction partners.
Proximity Ligation Assay (PLA): Combine YJR141W Antibody with antibodies against potential interaction partners to visualize protein-protein interactions in situ with single-molecule resolution.
Chromatin Immunoprecipitation (ChIP): If YJR141W functions in DNA-binding complexes, use the antibody to identify genomic binding sites through ChIP followed by sequencing.
Protein Complex Isolation: Use the antibody in tandem affinity purification or sequential immunoprecipitation approaches to isolate intact protein complexes containing YJR141W.
Yeast Two-Hybrid Validation: Confirm Y2H screening results by co-immunoprecipitation using YJR141W Antibody.
These approaches can provide complementary data about YJR141W's protein interaction network and functional roles in cellular processes .
For quantitative analysis of YJR141W protein, researchers can employ several approaches:
Quantitative Western Blotting:
Use internal loading controls (e.g., GAPDH, actin)
Employ standard curves with recombinant YJR141W protein
Utilize digital imaging systems with linear dynamic range
Apply densitometric analysis with appropriate normalization
Quantitative ELISA:
Develop a sandwich ELISA using YJR141W Antibody as capture or detection antibody
Generate standard curves using purified recombinant YJR141W
Optimize blocking, washing, and detection conditions for maximum sensitivity
Flow Cytometry:
For intracellular staining of YJR141W in permeabilized yeast cells
Use appropriate fluorophore-conjugated secondary antibodies
Include calibration beads for quantitative measurements
Automated Image Analysis:
For immunofluorescence applications
Apply machine learning algorithms to quantify protein expression in subcellular compartments
Use appropriate imaging controls for normalization
Multiplexed Protein Quantification:
Combine YJR141W Antibody with antibodies against other proteins in multiplex assays
Utilize differentially labeled secondary antibodies for simultaneous detection
These quantitative approaches provide rigorous methods for measuring YJR141W protein levels under various experimental conditions .
Integrating YJR141W Antibody into systems biology research enables comprehensive understanding of this protein's role in broader cellular networks:
Proteome-Wide Interaction Mapping:
Use YJR141W Antibody in affinity purification-mass spectrometry (AP-MS) workflows
Identify condition-specific protein interaction networks under various stresses or growth conditions
Multi-Omics Integration:
Correlate protein expression data from YJR141W Antibody experiments with transcriptomic data
Integrate results with metabolomic or phosphoproteomic datasets to create comprehensive cellular models
High-Content Screening:
Apply YJR141W Antibody in automated microscopy-based screens
Analyze phenotypic consequences of genetic or chemical perturbations on YJR141W localization or expression
Temporal Dynamics Analysis:
Use the antibody to track YJR141W protein levels across cell cycle phases or in response to environmental changes
Develop mathematical models of protein regulation based on quantitative time-course data
Cross-Species Comparative Analysis:
If the antibody cross-reacts with homologous proteins in related yeast species, use it to compare expression patterns evolutionarily
Relate findings to conserved cellular functions across species
These integrated approaches place YJR141W in its broader biological context, advancing our understanding of yeast cellular systems .